Advertisement

Die Beziehungen zwischen Resistenz, Allergie und Immunität bei der Tuberkulose

  • Enno Freerksen
  • Magdalena Rosenfeld
Part of the Tuberkulose-Forschungsinstitut Borstel book series (TBC BORSTEL, volume 1956/57)

Zusammenfassung

Es ist unbestritten, daß es eine von Natur aus vorhandene Widerstandskraft von Makroorganismen gegen den tuberkulösen Infekt gibt. Definitionsgemäß ist sie mit Resistenz zu bezeichnen. Leider halten sich nicht alle Autoren konsequent an diese Definition und setzen Resistenz oft synonym mit „Immunität“225. Das muß jedoch zu Unklarheiten führen. Der Begriff „Immunität“ sollte für den durch Erstinfekt erworbenen Schutz gegen einen Zweitinfekt reserviert werden. Die Resistenz bedarf keines Vorinfektes und ist ohne erkennbare Mitwirkung von Antigenen im Genbestand des Individuums verankert. Sie ist prinzipiell von der Immunität unterschieden. Bei dem unspezifischen Charakter der Resistenz kann es Antikörper im strengen Sinn des Wortes nicht geben; sie könnte natürlich trotzdem serologisch faßbar sein184–186.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Albertini, A. v., M. N. Metaxas u. M. Metaxas-Bühler: Über das gleichzeitige Einsetzen von Allergie und Tuberkelbildung bei der Meerschweinchentuberkulose. Schweiz. Z. allg. Path. u. Bakter. 19, 1–13 (1956).Google Scholar
  2. 2.
    Ambert, P., et R. Capet: Perspectives modernes de la biologie du bacille de Koch. Revue de la Tbc. 20, 488–496 (1956).Google Scholar
  3. 3.
    Aoyama, K.: Tuberculin-allergy as viewed from nucleinemia. Acta tbc. scand. (Københ.) 31, 294–318 (1955).Google Scholar
  4. 4.
    Aronson, J. D.: The specific cytotoxic action of tuberculin in tissue culture. J. of Exper. Med. 54, 387 (1931).Google Scholar
  5. 5.
    Aronson, J. D., and Charlotte Ferguson-Aronson: The correlation of the tuberculin reaction with roentgenographically demonstrable pulmonary lesions in BCG-vaccinated and control persons. Amer. Rev. Tbc. 68, 713–726 (1953).Google Scholar
  6. 6.
    Aronson, J. D., Helen C. Taylor and D. L. Kirk: The effects of isoniazid treatment on the tuberculin reaction and on the healing of BCG vaccine induced ulcers. Amer. Rev. Tbc. 74, 7–14 (1956).Google Scholar
  7. 7.
    Asselineau, J.: Lipides du bacille tuberculeux. Construction chimique et activitébiologique. Fortschr. Tbk.forsch. 5, 1 (1952).Google Scholar
  8. 8.
    Bail, O.: Übertragung der Tuberkulmempfindlichkeit. Z. Immun.forsch. 4, 470 (1910).Google Scholar
  9. 9.
    Baldridge, G. D., and A. M. Kligman: Nature of tuberculin reaction: Failure to demonstrate in vitro cytotoxicity for cells of sensitized animals. Amer. Rev. Tbc. 63, 674 (1951).Google Scholar
  10. 10.
    Bergsmann, O., u. F. Karlhuber: Hyperergische Tuberkuloseformen und ihre Beeinflußbarkeit durch Cortison. Ärztl. Forsch. 11, 187 (1957).Google Scholar
  11. 11.
    Besta, B.: Die Überfunktion der Nebennierenrinde bei tuberkulösen Er-krankungen. Beitr. Klin. Tbk. 113, 125 (1955).Google Scholar
  12. 12.
    Bettega, J. E.: PAS and tuberculin allergy. Clin. Tisiol. 8, 63 (1953).Google Scholar
  13. 13.
    Bieling, R.: Allergie und Infektionsablauf. Med. u. Chem. 2, 76–92 (1934).Google Scholar
  14. 14.
    Bieling, R.: Experimentelle Untersuchungen über Immunität bei Tuber-kulose. Erg. Tbk.forsch. 10, 237–276 (1941).Google Scholar
  15. 15.
    Bieling, R., u. L. Oelrichs: Untersuchungen über das Zustandekommen der Resistenz gegen Zweitinfektionen mit Kochbacillen. Beitr. Klin. Tbk. 88, 265–373 (1936).Google Scholar
  16. 16.
    Bieling, R., u. L. Oelrichs: Über die Beziehungen von Allergie und Im-munität bei Tuberkulose. Beitr. Klin. Tbk. 90, 491–505 (1937).Google Scholar
  17. 17.
    Blasi, A., e G. Curci: Experimentelle Untersuchungen über die orale BCG-Impfung nach A. de Assis. O. Hospital (Rio de Jan.) 47, 215 (1955).Google Scholar
  18. 18.
    Bloch, H.: Immunität bei Tuberkulose. Dtsch. med. Wschr. 1955, 1685.Google Scholar
  19. 19.
    Bloch, H.: The role of bacterial multiplication in the establishment of immunitv to tuberculosis. In: Ciba Foundation Symposium, London 1955, S. 237-245.Google Scholar
  20. 20.
    Bloch, H.: Studies on the virulence of tubercle bacilli. Isolation and biological properties of a constituent of virulent organism. J. of Exper. Med. 91, 197–218 (1950).Google Scholar
  21. 21.
    Bloch, H., and W. Segal: Viability and multiplication of vaccines in immunization against tuberculosis. Amer. Rev. Tbc. 71, 228–248 (1955).Google Scholar
  22. 22.
    Bollag, W.: Serologischer Nachweis von individualspezifischen Gewebs-antikörpern. Schweiz, med. Wschr. 1956, 687.Google Scholar
  23. 23.
    Boquet, A.: Substances antihistaminiques et réactions tuberculiniques. Ann. Inst. Pasteur 69, 55 (1943).Google Scholar
  24. 24.
    Brandt, N. G., C. N. Sandage and J. M. Birkeland: Effect of intravenous injection of tuberculin on leucocytes of normal and tuberculous rabbits. Proc. Soc. Exper. Biol. a. Med. 74, 315 (1950).Google Scholar
  25. 25.
    Brownlee, G., and D. G. Madigan: Tuberculous hypersensitivity and desensitization. In: Ciba Foundation Symposium London 1955, S. 211-236.Google Scholar
  26. 26.
    Buckley, J. J., S. M. Buckley and M. L. Keeve: Tissue culture studies on liver cells of tuberculin sensitized animals in presence of tuberculin (PPD). Bull. Johns Hopkins Hosp. 89, 303 (1951).PubMedGoogle Scholar
  27. 27.
    Bunn, P., and B. Drobeck: Use of rabitt eye as a tissue to study tuberculosis. III. Effect of adrenal hormones upon course of disease and upon certain immunologic responses. Amer. Rev. Tbc. 66, 175–187 (1952).Google Scholar
  28. 28.
    Cambell, G. D., R. H. Briggs and H. Boswell: Adrenocortical function in pulmonary tuberculosis. Amer. Rev. Tbc. 66, 364–372 (1952).Google Scholar
  29. 29.
    Canda, R. O., D. T. Carr, R. H. Ebert, D. S. Howlett jr., W. M. M. Kirby, R. S. Mitchell, W. M. Peck and N. J. Wilson: The effect of cortisone and/or corticotropin on tuberculous infection in man. Amer. Rev. Tbc. 66, 254–256 (1952).Google Scholar
  30. 30.
    Catel, W., u. W. Schmidt: Klinische und experimentelle Untersuchungen über das Wesen der lokalen Tuberkulinempfindlichkeit. Dtsch. med. Wschr. 1950, 1140.Google Scholar
  31. 31.
    Chase, M. W.: The cellular transfer of cutaneous hypersensitivity to tuberculin. Proc. Soc. Exper. Biol. a. Med. 59, 134 (1945).Google Scholar
  32. 32.
    Choremis, C, J. Allamanis and D. Zoumboulakis: The effect of cortisone on electrophoretic patterns and the hemagglutination reaction in the course of childhood tuberculosis. Amer. Rev. Tbc. 73, 964 (1956).Google Scholar
  33. 33.
    Chourcroun, N.: Tuberculous allergy induced in humans with chemical constituents of tubercle bacillus. Federat. Proc. 11, 464 (1952).Google Scholar
  34. 34.
    Cole, L. R., and C. B. Favour: Correlations between plasma protein fractions, antibody titers and the passive transfer of delayed and immediate cutaneous reactivity to tuberculin PPD and tuberculopolysaccharides. J. of Exper. Med. 101, 391 (1955).Google Scholar
  35. 35.
    Cornelson, D., u. Mitarb.: C. r. du 1er Congr. Internat, du BCG, Paris 1948, S. 68.Google Scholar
  36. 36.
    Cornforth, J. W., and D. A. Long: Influence of organic phosphates on tuberculin sensitivity in BCG-infected guinea pigs: Relation to cortisone desensiti-zation. Lancet 1952I, 950.Google Scholar
  37. 37.
    Cournand, A., and M. S. Lester: Skin reactions due to tubercle bacillus polysaccharides. Proc. 3rd Internat. Congr. Microbiol. New York 1939, S. 621.Google Scholar
  38. 38.
    Criep, L. H., and M. I. Levine: Effect of isoniazid on the tuberculin test. Amer. Rev. Tbc. 67, 535 (1953).Google Scholar
  39. 39.
    Criep, L. H., M. I. Levine and. T. H. Aaron: Inhibition of the tuberculin type reaction by antihistaminic drugs and Rutin. Amer. Rev. Tbc. 59, 701 (1949).Google Scholar
  40. 40.
    Cruickshank, R.: Infection and immunity in the individual. In Heaf, Symposium of Tuberculosis, London 1957, S. 41-64.Google Scholar
  41. 41.
    Cruickshank, R.: Sensitivity to tuberculin. Nature (Lond.) 168, 206 (1951).Google Scholar
  42. 42.
    Crumb, C, P. Meier and Florence B. Seibert: Effects of simultaneous skin tests on size of tuberculin reactions. Amer. Rev. Tbc. 65, 201–205 (1952).Google Scholar
  43. 43.
    Cummings, M. M., and P. C. Hudgins: The influence of cortisone on the passive transfer of tuberculin hypersensitivity in the guinea pig. J. of Immun. 69, 331 (1952).Google Scholar
  44. 44.
    Cummings, M. M., M. Hoyt and R. Y. Gottschall: Passive transfer of tuberculin sensitivity in the guinea pig. Publ. Health Rep. 1947, 994.Google Scholar
  45. 45.
    Cummings, M. M., R. A. Patnode and P. C. Hudgins: Passive transfer of tuberculin hypersensitivity in guinea pigs using cells disrupted by sonic vibration. Amer. Rev. Tbc. 73, 246–250 (1956).Google Scholar
  46. 46.
    Daniels, M., F. Ridehalgh, W. H. Springett and I. M. Hall: Tuberculosis in young adults. Report on the Prophit Tuberculosis Survey 1935-1944, London 1948.Google Scholar
  47. 47.
    Diehl, K.: Tierexperimentelle Erbforschung bei der Tuberkulose. Beitr. Klin. Tbk. 97, 333 (1942).Google Scholar
  48. 48.
    Diehl, K.: Das Erbe als Gestaltungsfaktor der Tuberkulose. In Bräuning, Allgemeine Biologie und Pathologie der Tuberkulose. Leipzig 1943.Google Scholar
  49. 49.
    Diehl, K.: Die Anlage zur Lungentuberkulose. Biol. Zbl. 66, 345 (1947).Google Scholar
  50. 50.
    Diehl, K., u. Fischer: Experimente über die Tuberkulose bei Kaninchen. Erbarzt 8, H. 5 (1940).Google Scholar
  51. 51.
    Diehl, K., u. O v. Verschuer: Zwillingstuberkulose. Jena 1933.Google Scholar
  52. 52.
    Diehl, K., u. O. v. Verschuer: Der Erbeinfluß bei der Tuberkulose (Zwil-lingstuberkulose II). Jena 1936.Google Scholar
  53. 53.
    Dienes, L., and T. B. Mallory: The influence of allergy on the development of early tuberculous lesions. Amer. J. Path. 13, 897 (1937).PubMedGoogle Scholar
  54. 54.
    Dubos, R. J., C. H. Pierce and W. B. Schaefer: Antituberculous immunity induced in mice by vaccination with living cultures of attenuated tubercle bacilli. J. of Exper. Med. 97, 207–220 (1953).Google Scholar
  55. 55.
    Dubos, R. J., W. B. Schaefer and C. H. Pierce: Antitubercutous immunity in mice vaccinated with killed tubercle bacilli. J.of Exper. Med. 97, 221–233 (1953).Google Scholar
  56. 56.
    Dubos, R. J., D. W. Weiss and R. W. Schaedler: Enhancing effect of adjuvants on the antituberculous immunity elicited in mice by methanol extracts of tubercle bacilli. Amer. Rev. Tbc. 73, 781 (1956).Google Scholar
  57. 57.
    Dye, W. E., Gladys L. Hobby, G. Middlebrook, F. Princi and G. P. Youmans: The effect of cortisone and/or corticotropin on experimental tuber-colous infections in animals. Amer. Rev. Tbc. 66, 257 (1952).Google Scholar
  58. 58.
    Ebert, R. H.: In vivo observations on the effect of cortisone on experimental tuberculosis using the rabbit ear chamber technique. Amer. Rev. Tbc. 65, 64 (1952).Google Scholar
  59. 58a.
    Ebert, R. H., and R. W. Wissler: In vivo observations on the effects of cortisone on the vascular reaction to large doses of horse serum, using the rabbit ear technique. J. Labor. a. Clin. Med. 38, 497 (1951).Google Scholar
  60. 59.
    Ederstrom, H. E., C. Calman and R. R. di Gangi: Antihistamine therapy in experimental shock. Proc. Soc. Exper. Biol. a. Med. 74, 104–106 (1950).Google Scholar
  61. 60.
    Edson, N. L.: Mortality from tuberculosis in Maori race. New Zeal and Med. J. 42, 102 (1943).Google Scholar
  62. 61.
    Fabrizio, Angelina M.: Effect of purified fractions of tuberculin on leuco-zytes from normal and tuberculous animals in tissue cultures. Amer. Rev. Tbc. 65, 250 (1952).Google Scholar
  63. 62.
    Favez, G., u. F. Agnet: Les indications de l’hydrocortisone et de la prednisone dans le traitement de la tuberculose pulmonaire evolutive. Schweiz, med. Wschr. 1956, 843.Google Scholar
  64. 63.
    Favour, C. B.: Lytic effects of bacterial products on lymphocytes of tuberculous animals. Proc. Soc. Exper. Biol. a. Med. 65, 269 (1947).Google Scholar
  65. 64.
    Favour, C.B., Barbara A. Harrison and C. K. Osgood: Increased in vitro tuberculin leucozyte cytolysis following a tuberculin skin test. Proc. Soc. Exper. Biol. a. Med. 73, 122–126 (1950).Google Scholar
  66. 65.
    Felber, J.: Allergie tuberculinique, allergie bacillaire et immunitéen tuberculose. Rev. méd. Suisse rom. 74, 154 (1954).PubMedGoogle Scholar
  67. 66.
    Fjelde, A. L., and H. Chr. Engbaek: The relationship of Mycobacteria and mammalian cells in tissue culture. Amer. Rev. Tbc. 75, 347 (1957).Google Scholar
  68. 67.
    Follis jr., R. H.: Studies on the cellular response in the early stages of the tuberculin reaction. Bull. Johns Hopkins Hosp. 66, 245 (1940).Google Scholar
  69. 68.
    Fong, J., Patricia Schneider and S. S. Elberg: Studies on tubercle bacillus monocyte relationship. II. Induction of monocyte degeneration by bacteria and culture filtrate. J. of Exper. Med. 105, 25–37 (1957).Google Scholar
  70. 69.
    Fourestier, M., u. A. Blaque-Belair: Experimentelle Grundlagen und biologische Bedeutung des positiven BCG-Tests. Beitr. Klin. Tbk. 115, 98 (1956).Google Scholar
  71. 70.
    Fotjrestier, M., u. A. Blaqtje-Belair: Technik und Ablesung, Empfindlichkeit und Unschädlichkeit des BCG-Tests. Beitr. Klin. Tbk. 115, 106 (1956).Google Scholar
  72. 71.
    Fourestier, M., u. A. Blaque-Belair: Klinische Bedeutung des BCG-Tests. Beitr. Klin. Tbk. 115, 115 (1956).Google Scholar
  73. 72.
    Fourestier, M., u. A. Blaque-Belair: Les „Anergies cutanées tuberculiniques “ et l’immunitédans l’infection tuberculeuse spontanée et après BCG, Bd. 1. Paris 1954.Google Scholar
  74. 73.
    Fourestier, M., u. A. Blaque-Belair: Etude critique de, l’allergie“ et de l’immunitédans l’infection tuberculeuse spontanée et après BCG. Presse méd. 1952, 669.Google Scholar
  75. 74.
    Freerksen, E.: Die Voraussetzungen für eine chemotherapeutische und antibiotische Therapie infektiöser Prozesse an Knochen und Gelenken. Jber. Borstel 1952/53, S. 177. 1954.Google Scholar
  76. 75.
    Freerksen, E.: Biologische Wirkungen des Isoniakotinsäurehydrazids. Jahresbericht Borstel 1952/53, S. 192-201. 1954.Google Scholar
  77. 76.
    Freerksen, E.: Tuberkuloseablauf und tuberkulostatische Therapie beim Versuchstier unter experimentell veränderten Bedingungen im inkretorischen Apparat. Jahresbericht Borstel 1952/53, S. 252-264. 1954Google Scholar
  78. 77.
    Freerksen, E.: Resistenz, Immunität, Allergie bei der Tuberkulose. Klin. Wschr. 1956, 881-887.Google Scholar
  79. 78.
    Freerksen, E.: Angeborene und erworbene Widerstandskraft bei der Tuberkulose. Tuberkulosearzt 11, 65–75 (1957).PubMedGoogle Scholar
  80. 79.
    Freersken, E., u. Magdalena Rosenfeld: Unveröffentlicht.Google Scholar
  81. 80.
    Freerksen, E., u. Hildegard Schellenberg: Die Vermehrung von Tuberkelbakterien in Monozyten gesunder Tiere. Z. Hyg. 142, 554–571 (1956).Google Scholar
  82. 81.
    Freerksen, E., u. H. Wolter: Unveröffentlicht.Google Scholar
  83. 82.
    Friedman, E., and I. Silverman: The effect of antihistaminic medication on the tuberculin reaction in children. Amer. Rev. Tbc. 60, 354 (1949).Google Scholar
  84. 83.
    Gell, P. G. H., and I. T. Hinde: The histology of the tuberculin reaction and its modification by cortisone. Brit. J. Exper. Path. 32, 516 (1951).Google Scholar
  85. 84.
    Gernez-Rieux, Ch., et C. Marchandise: La spécifitédes réactions cutanées tuberculiniques. Rev. d’Jmmunol. 1, 315 (1935).Google Scholar
  86. 85.
    Graub, M., and E. M. Barrist: The effect of antihistaminic drugs upon the tuberculin reaction. Amer. Rev. Tbc. 61, 735 (1950).Google Scholar
  87. 86.
    Greuel, H., u. E. L. Schäfer: Die Bedeutung einer Vorbehandlung mit ACTH, Cortison bzw. Doca für den Ablauf der experimentellen Meerschweinchentuberkulose. Z. Tbk. 108, 321 (1956).Google Scholar
  88. 87.
    Haas, H.: Histamin und Antihistamine. Aulendorf, Ed. Cantor 1951.Google Scholar
  89. 88.
    Haas, H.: Histamin und Antihistamine. 1. ergänzende Mitt. Arzneimittel-Forsch. 1, 277–280 (1951).Google Scholar
  90. 89.
    Haas, H.: Histamin und Antihistamine, 2. ergänzende Mitt. Arzneimittel-Forsch. 1, 362 (1951).Google Scholar
  91. 90.
    Haas, H.: Histamin und Antihistamine, 3. ergänzende Mitt. Arzneimittel-Forsch. 1, 407–412 (1951).Google Scholar
  92. 91.
    Haas, H.: Histamin und Antihistamine, 4. ergänzende Mitt. Arzneimittel-Forsch. 2, 34–40 (1952).Google Scholar
  93. 92.
    Haas, H.: Histamin und Antihistamin. 5. ergänzende Mitt. Arzneimittel-Forsch. 2, 79–84. (1952).Google Scholar
  94. 93.
    Haas, H.: Histamin und Antihistamine. 6. ergänzende Mitt. Arzneimittel-Forsch. 2, 127–139 (1952).Google Scholar
  95. 94.
    Halpern, B. N., et S. Cruchard: Prevention de l’oedème aigu de poumon expérimental par les antihistaminiques de synthèse. C. r. Soc. Biol. Paris 41, 1038 (1947).Google Scholar
  96. 95.
    Halpern, B. N., et S. Cruchard: Action préventive de l’antihistaminique n-dimethylamino-2-propyl-l-thiodiphenylamine sur l’oedème aigu expérimental du poumon provoquépar l’administration d’un gaz toxique: la chloropicrine. C. r. Acad. Sci. Paris 225, 1194 (1947).Google Scholar
  97. 96.
    Harris, Susanna, and T. N. Harris: Effect of cortisone on some reactions of hypersensitivity in laboratory animals. Proc. Soc. Exper. Biol. a. Med. 74, 186 (1950).Google Scholar
  98. 97.
    Haxthausen, H.: Passive transmission of dinitro-chlorobenzine allergy with white blood cells from sensitised guinea pigs. Acta dermat.-vener. (Stockh.) 31, 659 (1951).Google Scholar
  99. 98.
    Hayes, M. G., T. R. Pastor, L. R. Gaétan, R. A. S. Cory and E. R. Long: Tuberculin skin sensitivity in chronic tuberculosis in the course of hospital treatment. Amer. J. Med. Sci. 194, 286 (1957).Google Scholar
  100. 99.
    Heilmeyer, L.: Die Chemotherapie der Tuberkulose. Dtsch. med. Wschr. 1949, 161-167.Google Scholar
  101. 100.
    Henderson, A. R.: The effect of antihistamine medication on the tuberculin reaction. Amer. Rev. Tbc. 60, 811 (1949).Google Scholar
  102. 101.
    Hewell, B., and D. Suyemoto: Tuberculin reactions of tuberculous patients on isoniazid therapy. Amer. Rev. Tbc. 69, 733 (1954).Google Scholar
  103. 102.
    Hilson, G. R. F., and S. D. Elek: Haemagglutination reaction in tuberculosis. J. Clin. Path. 4, 158 (1951).PubMedGoogle Scholar
  104. 103.
    Hirsch, W. v., H. Dennhardt u. J. Hiller: Vergleichende Untersuchung der Tuberkulinempfindlichkeit bei unbehandelter und spezifisch behandelter Lungentuberkulose. Dtsch. Gesundheitswesen 8, 252 (1953).Google Scholar
  105. 104.
    Holst, P. M.: Studies on the effects of tuberculin. Tubercle 3, 337 (1922).Google Scholar
  106. 105.
    Howe, J. S.: Daily variations in the tuberculin reaction. Amer. Rev. Tbc. 37, 273 (1938).Google Scholar
  107. 106.
    Humphrey, J. H.: The effect of cortisone upon some experimental hypersensitivity reaction. Brit. J. Exper. Med. 32, 274 (1951).Google Scholar
  108. 107.
    Hunter, D., L. R. Hyde and J. D. Davis: The effect of antihistaminics on the tuberculin skin reaction. Amer. Rev. Tbc. 62, 525–531 (1950).Google Scholar
  109. 108.
    Jones, Ira S., and K. Meyer: Inhibition of vascularization of the rabbit cornea by local application of cortisone. Proc. Soc. Exper. Biol. a. Med. 74, 102 bis 104 (1950).Google Scholar
  110. 109.
    Kallös, P., u. Liselotte Kallös-Deffner: Die Bedeutung der chemischen Analyse des Tuberkuloseerregers und des Tuberkulins für die Tuberkuloseforschung. Zbl. Tbk.forsch. 42, 1 (1935).Google Scholar
  111. 110.
    Kirchheimer, W. F., and R. S. Weiser: The tuberculin reaction. I. Passive transfer of tuberculin sensitivity with cells of tubercolous guinea pigs. Proc. Soc. Exper. Biol. a. Med. 66, 166 (1947).Google Scholar
  112. 111.
    Kirchheimer, W. F., A. R. Hess and R. G. Spears: Attempts at passive transfer of tuberculin type of hypersensitivity with living granulocy tes. Amer. Rev. Tbc. 64, 516 (1951).Google Scholar
  113. 112.
    Kobayashi, K.: Influence of the autolysate of a certain kind of hetero-bacteria upon the blood cell formula of rabbits. Med. a. Biol. (Jap.) 9, 55 (1946).Google Scholar
  114. 113.
    Kobayashi, K.: The blood picture in pulmonary tuberculosis expecially its fluctuations following the hetero-specific alteration therapy. Rep. Nukada Inst. 1954, No 1.Google Scholar
  115. 114.
    Korb, G.: Die Tuberkulinreaktion und tuberkulostatische Therapie. Beitr. Klin. Tbk. 108, 353 (1953).Google Scholar
  116. 115.
    Kotjrilsky, R., et G. Decroix: Utilisation des cellules de l’exsudat péritonéal aseptique pour le transfert local de l’allergie tuberculinique. C. r. Soc. Biol. Paris 146, 235 (1952).Google Scholar
  117. 116.
    Kottrilsky, R., et M. Fourestier: Deux accidents radiologiquement et cliniquement identique à une primo-infection tuberculeuse chez un enfant à dix ans d’intervalle. Rev. de la Tbc. 12, 411 (1948).Google Scholar
  118. 117.
    Kottrilsky, R., G. Decroix et P. Ganter: Etudes sur l’allergie tuber-culinique: la transmission de l’allergie. Rev. d’Jmmunol. 16, 333 (1952).Google Scholar
  119. 118.
    Kracht, J., u. Gertrud Meissner: Wachstumshormon und Cortison bei experimenteller Tuberkulose mit unterschiedlicher Keimvirulenz. Frankf. Z. Path. 67, 391–405 (1956).Google Scholar
  120. 119.
    Kraus, E., et J. Dvorak: Allergie et immunitédes nourissons vaccinés par des doses massives de BCG per os selon la technique de de ASSIS. Presse méd. 1954, 1680.Google Scholar
  121. 120.
    Landsteiner, K., and M. W. Chase: Experiments in transfer of cutaneous sensitivity to simple compounds. Proc. Soc. Exper. Biol. a. Med. 49, 688 (1942).Google Scholar
  122. 121.
    Lane jr., J. J., E. R. Clarke jr. and T. H. Holmes: The relationship of tuberculin sensitivity and adrenocortical function in humans. Amer. Rev. Tbc. 73, 795–804 (1956).Google Scholar
  123. 122.
    Lange, Br.: Die experimentellen Grundlagen der Lehre von der Tuberkulose-immunität und Versuche einer Tuberkuloseschutzimpfung. In Bräuning, All-gemeine Biologie und Pathologie der Tuberkulose. S. 305-332. Leipzig 1943.Google Scholar
  124. 123.
    Lange, Br.: Versuche einer Tuberkuloseschutzimpfung. In Bräuning, All-gemeine Biologie und Pathologie der Tuberkulose. Leipzig 1943.Google Scholar
  125. 124.
    Lange, Br.: Die Verbreitungsweise der Tuberkulose, Infektionsquellen, Infektionswege, Eintrittspforten. In Bräuning, Allgemeine Biologie und Pathologie der Tuberkulose. Leipzig 1943.Google Scholar
  126. 125.
    Lange, Br.: Bakteriologie der Tuberkulose. A. Der Erreger. In Bräuning, Allgemeine Biologie und Pathologie der Tuberkulose. Leipzig 1943.Google Scholar
  127. 126.
    Langner, K.: Spezifische Antigenreaktionen an Leukocyten bei Tuberkulösen. Klin. Wschr. 1950, 177.Google Scholar
  128. 127.
    Laporte, R.: Histo-cytologie des réactions locales d’hypersensibilitéchez le cobaye. Ann. Inst. Pasteur 53, 598 (1934).Google Scholar
  129. 128.
    Lawrence, H. S.: Cellular transfer of cutaneous hypersensitivity to tuberculin in man. Proc. Soc. Exper. Biol. a. Med. 71, 516 (1949).Google Scholar
  130. 129.
    Lawrence, H. S.: The cellular transfer in humans of delayed cutaneous reactivity to hemolytic streptococci. J. of Immun. 68, 159 (1952).Google Scholar
  131. 130.
    Lawrence, H. S.: The transfer of general cutaneous hypersensitivity of delayed tuberculin type in man by means of constituents of disrupted leucocytes. J. Clin. Invest. 33, 951 (1954).Google Scholar
  132. 131.
    Lawrence, H. S.: The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes. J. Clin. Invest. 34, 219 (1955).PubMedGoogle Scholar
  133. 132.
    Leischke, Susanne: Die Veränderung der Tuberkulinreaktion durch vegetative Reizstoffe. Z. Tbk. 94, 171–186 (1950).Google Scholar
  134. 133.
    Leitner, St. J.: Tuberkulose und innere Sekretion. Zbl. Tbk.forsch 47, 1 (1937).Google Scholar
  135. 134.
    Lennox, B., W. J. Dempster and J. W. Boag: Supression of the tuberculin reaction in rabbits by total body irradiation with X-rays. Brit. J. Exper. Path. 33, 380 (1952).Google Scholar
  136. 135.
    Long, E. R.: The present status of the tuberculin test. (Minnesota) J. Lancet 62, 376 (1942).Google Scholar
  137. 136.
    Long, E. R., and S. W. Holley: The origin of epithelioid cells in experimental tuberculosis of the cornea. Amer. J. Path. 9, 337 (1933).PubMedGoogle Scholar
  138. 137.
    Long, E. R., S. W. Holley and A. J. Vorwald: A comparison of the cellular reactions in experimental tuberculosis of the cornea in animals of varying resistance. Amer. J. Path. 9, 329 (1933).PubMedGoogle Scholar
  139. 138.
    Long, E. R., and A. A. Miles: Opposite actions of thyroid and adrenal hormones in allergic hypersensitivity. Lancet 1950 I, 492.Google Scholar
  140. 139.
    Long, E. R., A. J. Vorwald and L. Donaldson: Early cellular reaction to tubercle bacilli: a comparison in normal and tuberculous guinea pigs. Arch. of Path. 12, 956 (1931).Google Scholar
  141. 140.
    Lurie, M. B., and P. Zappasodi: On the mode of action of cortisone on the pathogenesis of tuberculosis and its implications for the nature of genetic resistance to the disease. In: Ciba Foundation Symposium, London 1955, S. 246 bis 260.Google Scholar
  142. 141.
    Ltjrie, M. B., P. Zappasodi, Eugenia Cardona-Lynch and A. M. Dannen-berg jr.: The response to the intracutaneous inoculation of BCG as an index of native resistance to tuberculosis. J. of Immun. 68, 369–382 (1952).Google Scholar
  143. 142.
    Ltjrie, M. B., P. Zappasodi, A. M. Dannenberg jr. and G. H. Weiss: On the mechanism of genetic resistance to tuberculosis and its mode of inheritance. Amer. J. Human Genet. 4, 302 (1952).Google Scholar
  144. 143.
    Lydtin, K.: Diskussionsbemerkung zur Epidemiologie der Tuberkulose. Beitr. Klin. Tbk. 108, 26 (1953).Google Scholar
  145. 144.
    Lydtin, K.: Resistenz, Immunität und Durchseuchung bei Tuberkulose. Regensburger Jb. ärztl. Fortbildg 1, 1–7 (1950).Google Scholar
  146. 145.
    Lydtin, K.: Die Frage der Auslese bei der Tuberkulose. Erbarzt 1934, Nr 5, 73.Google Scholar
  147. 146.
    Lydtin, K.: Immunität und Schutzimpfung bei Tuberkulose. Klin. Wschr. 1930, 2281-2285.Google Scholar
  148. 147.
    Marks, J., and D. M. James: The effect of tuberculin on sensitized and normal leucocytes. J. of Hyg. 51, 340 (1953).Google Scholar
  149. 148.
    McCarter, J. R., and D. W. Watson: The relationship of the antigeni-city, physical-chemical properties and polysaccharide content of tuberculins to their intracutaneous activity. J. of Immun. 43, 85 (1942).Google Scholar
  150. 149.
    McJunkin, F. A.: Tuberculin hypersensitiveness in nontuberculous guinea pigs induced by injections of bacillus-free filtrates. J. of Exper. Med. 33, 751 (1921).Google Scholar
  151. 150.
    Metaxas, M. N., and M. Metaxas-Buhler: Passive transfer of local cutaneous hypersensitivity to tuberculin. Proc. Soc. Exper. Biol. a. Med. 69, 163 (1948).Google Scholar
  152. 151.
    Meynell, G. G.: The antigenic structure of M. tuberculosis var. hominis. J. of Path. 67, 137–150 (1954).Google Scholar
  153. 152.
    Michael, M., and C. M. Whorton: Delay of early inflammatory response by cortisone. Proc. Soc. Exper. Biol. a. Med. 76, 754 (1951).Google Scholar
  154. 153.
    Miller, J. M., and C. B. Favour: The lymphocytic origin of a plasma factor responsible for hypersensitivity in vitro of tuberculin type. J. of Exper. Med. 93, 1 (1951).Google Scholar
  155. 154.
    Moen, J. K., and H. F. Swift: Tissue culture studies in bacterial hypersensitivity. J. of Exper. Med. 64, 339, 943 (1936).Google Scholar
  156. 155.
    Molomut, N., D. M. Spain, S. D. Gault and L. Kreisler: The induction of métastases from sarcoma in C57BL/6 mice. Amer. J. Path. 30, 375–382 (1954).PubMedGoogle Scholar
  157. 156.
    Morgan, T. E., S. H. Wanzer and D. T. Smith: The effect of cortisone and streptomycin on experimentally induced pulmonary tuberculosis in rabbits. J. Bacter. 67, 257, 264 (1954).Google Scholar
  158. 157.
    Nakao, H., and M. Nobashiri: On the influence of a certain kind of hetero-bacteria upon the phagocytosis of tubercle bacilli. Mhon Igaku (Jap.) 1946, No 3403, 15.Google Scholar
  159. 158.
    Nilzen, A.: Some endocrine aspects of skin sensitization and primary irritation. J. Invest. Dermat. 18, 7 (1952).Google Scholar
  160. 159.
    Nukada, S., T. Kimura, K. Ohba u. C. Ryu: Über die Einflüsse minimaler Mengen von Heterobakterien auf den Verlauf der experimentellen Kaninchentuberkulose. III. Mitt. Beitr. Klin. Tbk. 94, 259–263 (1940).Google Scholar
  161. 160.
    Nukada, S., T. Kimttra, K. Ohba u. C. Ryu: Behandlung der experimentellen Kaninchentuberkulose mit Typhusbazillen-und Gonokokkenautolysat. Beitr. Klin. Tbk. 96, 459 (1941).Google Scholar
  162. 161.
    Nukada, S., T. Kimura, K. Ohba u. C. Ryu: Influence of the previous vaccination with autolysate of a certain kind of heterobacteria upon the experimental tuberculosis of rabbits. Trans. Jap. Path. Soc. 32, 500 (1942).Google Scholar
  163. 162.
    Nukada, S., T. Kimura, K. Ohba u. C. Ryu: Influence of the previous vaccination with autolysate of a certain kind of heterobacteria upon the superinfection of the experimental tuberculosis of rabbits. Trans. Jap. Path. Soc. 33, 76 (1943).Google Scholar
  164. 163.
    Nukada, S., T. Kimura, K. Ohba u. C. Ryu: Influence of the previous vaccination with autolysate of a certain kind of heterobacteria upon the mild superinfection of the experimental tuberculosis of rabbits. Trans. Jap. Path. Soc. 34, 106 (1944).Google Scholar
  165. 164.
    Nukada, S., and M. Okutani: Preventive effects of „Heterostate“ against tuberculosis. Med. a. Biol. (Jap.) 9, 32 (1946).Google Scholar
  166. 165.
    Nukada, S., u. C. Ryu: Über Schwankungen der Resistenz gegen tödliche hämatogene Tuberkelbazilleninfektion nach Immunisierung mit Heterobakterien. Z. Immun.forsch. 88, 496 (1936).Google Scholar
  167. 166.
    Nukada, S., u. C. Ryu: Über die Einflüsse minimaler Mengen von Heterobakterien auf den Verlauf der experimentellen hämatogenen Tuberkulose. Beitr. Klin. Tbk. 89, 449–468 (1937).Google Scholar
  168. 167.
    Nukada, S., u. C. Ryu: Über die Resistenz gegen eine tödliche hämatogene Tuberkelbazilleninfektion nach Vorbehandlung mit Typhusbazillen-und Gono-kokkenautolysat. Z. Immun.forsch. 98, 272 (1940).Google Scholar
  169. 168.
    Nukada, S., u. C. Ryu: Hetero-specific alteration therapy. Tokyo, Kyoto: The Jap. Med. Publications Co. Ltd. 1948.Google Scholar
  170. 169.
    Nukada, S., C. Ryu and T. Yoshii: Recent clinical experience in the treatment for pulmonary tuberculosis with minimal doses of certain kinds of heterobacteria. (Jap.) Kekkaku 15, 999 (1937).Google Scholar
  171. 170.
    Nukada, S., C. Ryu and T. Yoshii: Hetero-specific alteration therapy for pulmonary tuberculosis, especially its clinical results during a five year period (1940–1945). Lab. a. Clin. (Jap.) 1, 17 (1947).Google Scholar
  172. 171.
    Nyka, W.: Enhancement of resistance to tuberculosis in mice experimentally infected with Brucella abortus. Amer. Rev. Tbc. 73, 251–265 (1956).Google Scholar
  173. 172.
    Orlowski, E. H.: Die Hämagglutination-Hämolyse-Reaktion nach Middle-brook-Dubos. Tierexperimentelle Untersuchungen und klinische Ergebnisse. Jahresbericht Borstel 1956/57.Google Scholar
  174. 173.
    Osgood, C. M., and C. B. Favour: The effect of adrenocorticotrophic hormone on inflammation due to tuberculin hypersensitivity and turpentine, and on circulating antibody levels. J.of Exper. Med. 94, 415 (1951).Google Scholar
  175. 174.
    Palmer, C. E.: Tuberculin sensitivity and contact with tuberculosis. Further evidence of nonspecific sensitivity. Amer. Rev. Tbc. 68, 678 (1953).Google Scholar
  176. 175.
    Pancotto, L.: Allergometric, clinical and radiologie variations in patiensts treated with isoniazid. Policlinico 60, 205 (1953).Google Scholar
  177. 176.
    Paraf, J., et P. Morgange: Contribution à l’étude du phénomène de l’anergie tuberculinique au cours de la rougeole. Bull. Soc. méd. Hôp. Paris 52, 578 (1936).Google Scholar
  178. 177.
    Pepys, J.: Effect of the antihistaminic drugs on tissue reactions. Acta allergol. (Københ.) 4, 115 (1951).Google Scholar
  179. 178.
    Pepys, J.: Effect of local adrenaline and histamine on the tuberculin reaction. Acta allergol. (Københ.) 6, 265 (1953).Google Scholar
  180. 179.
    Pepys, J.: Fixation of tuberculin in the skin of tuberculin sensitive human subjects. Clin. Sci. (to be published).Google Scholar
  181. 180.
    Pepys, J.: The relationship of nonspecific and specific factors in the tuberculin reaction. Amer. Rev. Tbc. 71, 49–73 (1955).Google Scholar
  182. 181.
    Pestel, M.: The concept of immunity in human tuberculosis. Bull. Soc. méd. Hôp. Paris 1956, 31-38.Google Scholar
  183. 182.
    Pfaffenberg, R.: Bluteiweißbild und Tuberkelbakterienphagozytose bei Diabetikern mit Lungentuberkulose. III. Mitt. Z. inn. Med. 12, 252–258 (1957).Google Scholar
  184. 183.
    Pilcher, J. D.: Diminution in the circulation of the skin, a factor in descreasing the cutaneous tuberculin reaction. Amer. Rev. Tbc. 21, 669 (1931).Google Scholar
  185. 184.
    Pillemer, L.:The Proderdin System. Trans. N.Y. Acad Sci. 17, 526–530 (1955).Google Scholar
  186. 185.
    Pillemer, L., Livia Blum, I.-H. Lepow, O. A. Ross, E. W. Todd and A. C. Wardlaw: The Properdin System. I. Demonstration and Isolation of a new serum protein and its role in immune phenomena. Science (Lancaster, Pa.) 120, 279 bis 285 (1954).Google Scholar
  187. 186.
    Pillemer, L., M. D. Schoenberg, Livia Blum and Leone Würz: The Properdin System II. Science (Lancaster, Pa.) 122, 545–549 (1955).Google Scholar
  188. 187.
    Prigge, R.: Grundlagen und Möglichkeiten der Tuberkuloseschutzimpfung des Menschen. Med. Klin. 1948, 565, 597.Google Scholar
  189. 189.
    Rabe, H. H., u. H. Bürger: Bluteiweißuntersuchungen bei experimenteller Meerschweinchentuberkulose nach Infektion mit humanen Mykobakterien ver-schiedener Virulenzgrade und nach Superinfektion. Jahresbericht Borstel 1956/57.Google Scholar
  190. 190.
    Raffel, S.: The relationship of acquired resistance, allergy, antibody and tissue reactivities to the components of the tubercle bacillus. Amer. Rev. Tbc. 54, 564–573 (1946).Google Scholar
  191. 191.
    Raffel, S.: Types of acquired immunity against infectious disease. Annual Rev. Microbiol. 3, 221 (1949).Google Scholar
  192. 192.
    Raffel, S.: Chemical factors involved in the induction of infectious allergy. Experientia (Basel) 6, 410–419 (1950).Google Scholar
  193. 193.
    Raffel, S.: Immunity, Hypersensitivity, Serology. New York 1953.Google Scholar
  194. 194.
    Raffel, S.: The mechanism involved in acquired immunity to tuberculosis. In: Ciba Foundation Symp. London 1955, S. 261-282.Google Scholar
  195. 195.
    Raffel, S.: Immunopathology of tuberculosis. Amer. Rev. Tbc. 74, 2/2, 60–74 (1956).Google Scholar
  196. 196.
    Raffel, S., L. E. Arnaud, C. D. Dukes and J. S. Huang: The role of „wax“ of the tubercle bacillus in establishing delayed hypersensitivity. J. of Exper. Med. 90, 53 (1949).Google Scholar
  197. 197.
    Raffel, S., J. Asselineau and E. Lederer: The chemical nature of the lipoidal factor of the tubercle bacillus responsible for the induction of tuberculous hypersensitivity. In: Ciba Foundation Symp., London 1955, S. 174-187.Google Scholar
  198. 198.
    Raffel, S., and E mbach: Zit. nach Raffel, Amer. Rev. Tbc. 74,2/2, 60 (1956).Google Scholar
  199. 199.
    Rich, A. R.: The pathogenesis of tuberculosis, 2. Aufl. Springfield 1951.Google Scholar
  200. 200.
    Rich, A. R., and R. H. Follis: Studies on the site of sensitivity in the Arthus phenomenon. Bull. Johns Hopkins Hosp. 66, 106 (1940).Google Scholar
  201. 201.
    Rich, A. R., and M. R. Lewis: Mechanism of allergy in tuberculosis. Proc. Soc. Exper. Biol. a. Med. 25, 596 (1927/28).Google Scholar
  202. 202.
    Rich, A. R., and H. A. McCordock: An enquiry concerning the role of allergy, immunity and other factors of importance in the pathogenesis of human tuberculosis. Bull. Johns Hopkins Hosp. 44, 273 (1929).Google Scholar
  203. 203.
    Robinson, A., M. Meyer and G. Middlebrook: Tuberculin hypersensitivity in tuberculous infants treated with isoniazid. New England J. Med. 252, 983 (1955).Google Scholar
  204. 204.
    Robson, J. M., and K. A. Didcock: The action of cortisone on corneal tuberculosis studies with the phase contrast microscope. Amer. Rev. Tbc. 74, 1–6 (1956).Google Scholar
  205. 205.
    Römer, P. H.: Über intrakutane Tuberkulinanwendung zu diagnostischen Zwecken. Beitr. Klin. Tbk. 12, 185 (1909).Google Scholar
  206. 208.
    Sandage, C. N., and J. M. Birkeland: Effect of intravenous tuberculin injections on subsequent tuberculin skin reactions in hypersensitive rabbits. Amer. Rev. Tbc. 61, 556 (1950).Google Scholar
  207. 207.
    Sarber, R. W.: Effect of benadryl hydrochloride on the tuberculin reaction in guinea pigs. Amer. Rev. Tbc. 57, 504 (1948).Google Scholar
  208. 208.
    Sayé, L.: Contribution à l’étude de la réaction de réinfection et de la sensibilitéà la tuberculine chez des enfants vaccinés avec le BCG sec par voie digestive. Presse méd. 1953, 524.Google Scholar
  209. 209.
    Seeberg, G.: Intradermal reactions of the delayed type in relation to the absorptive behaviour of the skin. Acta dermato-vener. 27, Suppl. 18 (1947).Google Scholar
  210. 210.
    Segal, W., and H. Bloch: Pathogenic and immunogenic differentiation of mycobacterium tuberculosis grown in vitro and in vivo. Amer. Rev. Tbc. 75, 495 (1957).Google Scholar
  211. 211.
    Seibert, Florence B.: The isolation of three different proteins and two polysaccharides from tuberculin by alcohol fractionation. Amer. Rev. Tbc. 59, 86 (1949).Google Scholar
  212. 212.
    Seibert Florence B, and Angelina M. Fabrizio: The isolation and chemistry of a protein fraction of M. tuberculosis and its ability to sensitze cells. Amer. Rev. Tbc. 66, 314 (1952).Google Scholar
  213. 213.
    Seibert, Florence B., and E. H. Dufoijr: Comparison between the standard tuberculins, PPD-S and Old Tuberculin. Amer. Rev. Tbc. 69, 585 (1954).Google Scholar
  214. 214.
    Seibert, Florence B., J. W. Nelson and Mabel V. Seibert: Correlation of extent of tuberculosis with amount of polysaccharide in the serum. Proc. Soc. Exper. Biol. a. Med. 52, 219 (1943).Google Scholar
  215. 215.
    Seibert, Florence B., K. O. Pedersen and A. Tiselius: Molecular weight, electrochemical and biological properties of tuberculin protein and polysaccharide molecules. J. of Exper, Med. 68, 413 (1938).Google Scholar
  216. 216.
    Seibert, Florence B., Eva Soto Fegueroa and Emma H. Dufour: Isolation, identification and classification of proteins of tuberculin and the tubercle bacillus. Amer. Rev. Tbc. 71, 704 (1955).Google Scholar
  217. 217.
    Shepard, C. C.: Growth characteristics of tubercle bacilli and certain other mycobacteria in HeLa cells. J. of Exper. Med. 105, 39 (1957).Google Scholar
  218. 218.
    Sherris, J. C.: The Middlebrook-Dubos haemagglutination test and its haemolytic modification in the diagnosis of tuberculosis. J. Clin. Path. 6, 64 (1953).PubMedGoogle Scholar
  219. 219.
    Siems, K. J., and J. Kracht: Zur Wirkung des Follikelhormons auf die weibliche Genitaltuberkulose. Zbl. Gynäk. 76, 1975 (1954).Google Scholar
  220. 220.
    Smithburn, K. C, and F. R. Sabin: Reactions of normal and tuberculous animals to tuberculoprotein and tuberculo-phosphatide. J. of Exper. Med. 68, 641 (1938).Google Scholar
  221. 221.
    Spada, E.: Modifications in tuberculin allergy in the course of treatment with isoniazid. Minerva med. (Torino) 1953, 806.Google Scholar
  222. 222.
    Sudeck, G. H.: Gewebliche Reaktion nach Diphtherietoxin bei normalen und hypophysektomierten Meerschweinchen. Jahresbericht Borstel 1952/53, S.693.1954.Google Scholar
  223. 223.
    Schäfer, E. L.: Tuberkulose und innere Sekretion. Med. Klin. 1952, 1303.Google Scholar
  224. 224.
    Schäfer, E. L.: Tuberkulose und innere Sekretion. Erg. Tbk.forsch 12, 209 (1954).Google Scholar
  225. 225.
    Schlossberger, H., u. I. Eckart: Allgemeine Epidemiologie. In Handbuch der inneren Medizin, 4. Aufl., Bd. I/l, S. 1-99. Berlin 1952.Google Scholar
  226. 226.
    Schmid, F.: Die passive Übertragung der Tuberkulinallergie. Beitr. Klin. Tbk. 105, 397 (1951).Google Scholar
  227. 227.
    Schmid, F.: Mesenchymale Derivate und Tuberkulinallergie. Z. Kinder-heilk. 70, 459 (1952).Google Scholar
  228. 228.
    Schwartz, S.: The tuberculin reaction during chemotherapy for tuberculosis. Dis. Chest 31, 286 (1957).PubMedGoogle Scholar
  229. 229.
    Stacey, M.: The proteins of the tubercle bacillus. In: Ciba-Foundation Symposion, London, 1955, p. 5-13.Google Scholar
  230. 230.
    Stavitsky, A. B.: Passive cellular transfer of the tuberculin type of hypersensitivity. Proc. Soc. Exper. Biol. a. Med. 71, 225 (1948).Google Scholar
  231. 231.
    Steenken jr., W., and L. U. Gardner: Vaccinating properties of avirulent dissociates of five different strains of tubercle bacilli. Yale J. Biol. a. Med. 15, 393 (1942/43).Google Scholar
  232. 232.
    Stein, S. C, and J. D. Aronson: The occurence of pulmonary lesions in BCG vaccinated and un vaccinated persons. Amer. Rev. Tbc. 68, 695 (1953).Google Scholar
  233. 233.
    Steiner, M., and B. Zuger: Allergy and immunity in tuberculosis. I. J. of Immun. 46, 83 (1943).Google Scholar
  234. 234.
    Steiner, M., and S. Wigniolle: Contribution à l’étude de l’allergie cutanée par la tuberculine et le test au BCG. Schweiz. Z. Tbk. 6, 417 (1953).Google Scholar
  235. 235.
    Stewart, E. W., P. H. Long and J. T. Bradley: The fate of reacting leucocytes in the tuberculin and reinfection reactions. Amer. J. Path. 2, 47 (1926).PubMedGoogle Scholar
  236. 236.
    Sträub, D. L.: Sepsis tuberculosa acutissima nach Behandlung mit Corti-son und ACTH. Diss. Basel 1955.Google Scholar
  237. 237.
    Tonutti, E.: Desoxycorticosteron und Cortison bei Di-Vergiftung. Arzneimittel-Forsch. 2, 97 (1952).Google Scholar
  238. 238.
    Trautwein, H.: Blutbild, Knochenmarksbild und Bluteiweißbild bei Tuberkulose. Beitr. Klin. Tbk. 114, 441 (1955).Google Scholar
  239. 239.
    Trowell, O.A.: The sensitivity of lymphocytes to ionising radiation. J. of Path. 64, 687 (1952).Google Scholar
  240. 240.
    Tuberculosis Programm, Public Health Service USA: Experimental studies of vaccination, allergy and immunity in tuberculosis. I. Design for a research program. Bull. World Health Org, 12, 13 (1955).Google Scholar
  241. 241.
    Tuberkulosis Program, Public Health Service USA: Experimental studies of vaccination, allergy and immunity in tuberculosis. II. Effect of varying the dose of BCG. Bull. World Health Org. 12, 31 (1955).Google Scholar
  242. 242.
    Tuberculosis Program, Public Health Service USA: Experimental studies of vaccination, allergy and immunity in tuberculosis. III. Effect of killed BCG vaccine. Bull. World Health Org. 12, 47 (1955).Google Scholar
  243. 243.
    Tuberculosis Program, Public Health Service USA: Experimental studies of vaccination, allergy and immunity in tuberculosis. IV. Comparison of effects of BCG and H37Ra vaccines. Amer. J. Hyg. 62, 168 (1955).Google Scholar
  244. 244.
    Tuberculosis Program, Public Health Service USA: Experimental studies of vaccination, allergy and immunity in tuberculosis. V. Relation between degree of tuberculin sensitivity and resistance in the vaccinated animal Amer. J. Hyg. 62, 185 (1955).Google Scholar
  245. 245.
    Tuberculosis Program, Public Health Service USA: Experimental studies of vaccination, allergy and immunity in tuberculosis. VI. Comparative effects of BCG, H37Ra, M. phlei and a wax-protein fraction of human tubercle bacilli. Amer. J.Hyg. 62, 200 (1955).Google Scholar
  246. 246.
    Uvstedt, H. J.: Usual and unusual reactions to BCG inoculation in children. Amer. Rev. Tbc. 74, 2/2, 32 (1956).Google Scholar
  247. 247.
    Vollmer, H.: Effect of hyaluronidase on skin reactions to the tuberculin patch test. Amer. J. Dis. Childr. 80, 59 (1950).Google Scholar
  248. 248.
    Vollmer H.: The local effect of cortisone on the tuberculin reaction. J. of Pediatr. 39, 22 (1951).Google Scholar
  249. 249.
    Vorwald, A. J., M. Dworski, P. C. Pratt and A. B. Delahant: BCG vaccination in silicosis. Amer. Rev. Tbc. 62, 455 (1950).Google Scholar
  250. 250.
    Vorwald, A. J., M. Dworski, P. C. Pratt and A. B. Delahant: BCG vaccination of silicosis. II. Amer. Rev. Tbc. 69, 766 (1954).Google Scholar
  251. 251.
    Wassen, E.: Ein Versuch mit sog. „Deposition“ von Tuberkulin intra-cutan bei nicht tuberkulinempfindlichen Individuen. Beitr. Klin. Tbk. 88, 217 1936).Google Scholar
  252. 252.
    Wassen, E.: Weitere Versuche mit sog. intracutaner Deposition von Tuberkulin bei nicht tuberkulinempfindlichen Individuen. Beitr. Klin. Tbk. 92, 515 (1939).Google Scholar
  253. 253.
    Wassen, E., u. B. Swedin: Versuche mit Depottuberculin am Kaninchen. Beitr. Klin. Tbk. 96, 206 (1941).Google Scholar
  254. 254.
    Weiser, R. S., Erica Evans and Leone St. Vincent: Tuberculin reaction IV. Failure of Pyribenzamine to protect against systemic tuberculin shock. Proc. Soc. Exper. Biol. a. Med. 73, 303 (1950).Google Scholar
  255. 255.
    Wells, A. Q., and J. A. H. Wylie: The persistence of resistance following the disappearance of hypersensitivity in guinea pigs after vaccination with vole bacillus and BCG. Brit. J. Exper. Path. 33, 405 (1952).Google Scholar
  256. 256.
    Wesslén, T.: Studies on the role of lymphocytes in antibody production. Acta dermato-vener. (Stockh.) 32, 265 (1952).Google Scholar
  257. 257.
    Wesslén, T.: Passive transfer of tuberculin hypersensitivity by viable lymphocytes from the thoracic duct. Acta tbc. scand. (Københ.) 26, 38 (1952).Google Scholar
  258. 258.
    Wetzel, U.: Die Tuberkulose bei Heimkehrern. Beitr. Klin. Tbk. 102, 519 (1950).Google Scholar
  259. 259.
    Wetzel, U.: Cortisonbehandlung des Erythema nodosum. Ther. Gegenw. 1956, 147.Google Scholar
  260. 260.
    White, R. G., A H. Coons and J. M. Conolly: Studies on antibody production. IV. The role of a wax fraction of M. tuberculosis in adjuvant emulsions on the production of antibody to egg albumin. J. of Exper. Med. 102, 83 (1955).Google Scholar
  261. 261.
    WHO Tuberculosis Research. Office: Further studies of geographic variation in naturally acquired tuberculin sensitivity. Bull. World Health Org. 12, 63 (1955).Google Scholar
  262. 262.
    Wiles, E.: A psychiatrist looks at tuberculosis. N.A.P.T. 1949.Google Scholar
  263. 263.
    Willis, H. S., C. Woodruff, R. G. Kelly and M. Voldrich: Allergic and desensitized guinea pigs. Amer. Rev. Tbc. 38, 10 (1938).Google Scholar
  264. 264.
    Woodruff, C. E.: A free growth period of tubercle bacilli in the guinea pig omentum as related to the hypersensitive state. Amer. J. Path. 10, 739 (1934).PubMedGoogle Scholar
  265. 265.
    Woodruff, C. E.: Antihistaminics and the tuberculin reaction. Amer. Rev. Tbc. 62, 555 (1950).Google Scholar
  266. 266.
    Zebrowski, T.: Beobachtungen über immunisierende Eigenschaften der säurefesten Saprophyten. Beitr. Klin. Tbk. 115, 347 (1956).Google Scholar
  267. 267.
    Zuger, B., and M. Steiner: Allergy and immunity in tuberculosis. II. Relationship of tuberculin cutaneous reactivity to experimental infection in the guinea pig. J. of Immun. 46, 91 (1943).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1957

Authors and Affiliations

  • Enno Freerksen
  • Magdalena Rosenfeld

There are no affiliations available

Personalised recommendations